Malaysia Shares Sink Most Since 2008 Crisis as Foreigners Bail

It was a pretty bad day for Asian stock markets. For Malaysia, it was even worse.

The FTSE Bursa Malaysia KLCI Index plunged as much as 3.7 percent, with losses snowballing after the midday break. The gauge ended the session 3.2 percent lower, its biggest single-day slump since October 2008, with declines surpassing those of all other national benchmarks in the region. Malaysian markets were shut on Tuesday for a holiday.

#lazy-img-328155384:before{padding-top:56.25%;}

Builders suffered the brunt of the selling as Gamuda Bhd. sank as much as 27 percent after Prime Minister Mahathir Mohamad said the government would cancel a proposed multibillion-dollar, high-speed railway link to Singapore and the third phase of a mass rapid transit line in Kuala Lumpur. Banks also suffered, with Malayan Banking Bhd. down 4.3 percent amid a sector selloff.

The Malaysian index, which only last month traded at a record, is now down more than 9 percent from its peak as traders adjust to a new political environment. Foreign investors have fled the nation’s stocks, pulling money every single day this month -- a streak unseen since the selloff of August 2015.

LISTEN TO ARTICLE 1:10 Share Share on Facebook Post to Twitter Send as an Email Print

Franklin Resources Inc. Has $339.44 Million Holdings in Mattel (MAT)

Franklin Resources Inc. boosted its holdings in Mattel (NASDAQ:MAT) by 729.2% in the first quarter, according to its most recent filing with the SEC. The institutional investor owned 25,812,527 shares of the company’s stock after buying an additional 22,699,590 shares during the period. Franklin Resources Inc. owned 7.50% of Mattel worth $339,438,000 as of its most recent SEC filing.

A number of other hedge funds have also modified their holdings of MAT. Creative Planning increased its stake in Mattel by 42.1% in the 4th quarter. Creative Planning now owns 35,732 shares of the company’s stock worth $550,000 after buying an additional 10,595 shares in the last quarter. State of Alaska Department of Revenue grew its position in shares of Mattel by 53.1% during the fourth quarter. State of Alaska Department of Revenue now owns 82,588 shares of the company’s stock valued at $1,268,000 after purchasing an additional 28,640 shares in the last quarter. SG Americas Securities LLC grew its position in shares of Mattel by 289.5% during the fourth quarter. SG Americas Securities LLC now owns 367,093 shares of the company’s stock valued at $5,646,000 after purchasing an additional 272,856 shares in the last quarter. Meag Munich Ergo Kapitalanlagegesellschaft MBH purchased a new position in shares of Mattel during the fourth quarter valued at about $253,000. Finally, High Pointe Capital Management LLC purchased a new position in shares of Mattel during the fourth quarter valued at about $311,000.

Get Mattel alerts:

Shares of Mattel opened at $15.23 on Friday, Marketbeat reports. The company has a quick ratio of 1.56, a current ratio of 2.25 and a debt-to-equity ratio of 2.92. Mattel has a 12 month low of $12.21 and a 12 month high of $23.11. The stock has a market capitalization of $5.19 billion, a P/E ratio of -14.10 and a beta of 0.98.

Mattel (NASDAQ:MAT) last announced its quarterly earnings results on Thursday, April 26th. The company reported ($0.60) EPS for the quarter, missing the Zacks’ consensus estimate of ($0.39) by ($0.21). Mattel had a negative net margin of 25.79% and a negative return on equity of 32.79%. The business had revenue of $708.40 million during the quarter, compared to the consensus estimate of $687.70 million. During the same period in the previous year, the business posted ($0.32) EPS. The firm’s revenue was down 3.7% on a year-over-year basis. sell-side analysts forecast that Mattel will post -0.45 earnings per share for the current year.

A number of research analysts have recently weighed in on the company. BidaskClub upgraded Mattel from a “sell” rating to a “hold” rating in a research report on Wednesday, February 7th. Jefferies Group lowered Mattel from a “hold” rating to an “underperform” rating and set a $22.00 price objective for the company. in a research report on Monday, February 26th. Stifel Nicolaus restated a “hold” rating and set a $16.00 price objective on shares of Mattel in a research report on Monday, January 29th. Barclays raised their price objective on Mattel from $15.00 to $16.00 and gave the company an “equal weight” rating in a research report on Monday, February 5th. Finally, UBS set a $18.00 price objective on Mattel and gave the company a “buy” rating in a research report on Wednesday, February 21st. Two analysts have rated the stock with a sell rating, ten have given a hold rating and four have given a buy rating to the stock. Mattel currently has a consensus rating of “Hold” and an average target price of $17.83.

About Mattel

Mattel, Inc designs, manufactures, and markets a range of toy products worldwide. The company operates in three segments: North America, International, and American Girl. It offers Mattel Girls & Boys branded products, including Barbie dolls and accessories, Monster High, DC Super Hero Girls, Enchantimals, Polly Pocket, Hot Wheels and Matchbox vehicles and play sets, CARS, DC Comics, WWE Wrestling, Minecraft, Toy Story, and games and puzzles.

Brokerages Anticipate Cohu, Inc. (COHU) to Post $0.42 EPS

Equities research analysts expect Cohu, Inc. (NASDAQ:COHU) to report $0.42 earnings per share for the current quarter, according to Zacks. Two analysts have made estimates for Cohu’s earnings, with the highest EPS estimate coming in at $0.48 and the lowest estimate coming in at $0.32. Cohu reported earnings per share of $0.48 during the same quarter last year, which suggests a negative year over year growth rate of 12.5%. The business is scheduled to issue its next quarterly earnings results on Thursday, July 26th.

According to Zacks, analysts expect that Cohu will report full year earnings of $1.72 per share for the current financial year, with EPS estimates ranging from $1.67 to $1.75. For the next year, analysts expect that the company will post earnings of $2.03 per share, with EPS estimates ranging from $2.00 to $2.06. Zacks’ earnings per share averages are an average based on a survey of research analysts that that provide coverage for Cohu.

Get Cohu alerts:

Cohu (NASDAQ:COHU) last announced its earnings results on Tuesday, May 8th. The semiconductor company reported $0.36 EPS for the quarter, topping the Zacks’ consensus estimate of $0.33 by $0.03. Cohu had a return on equity of 14.10% and a net margin of 9.33%. The company had revenue of $95.20 million for the quarter, compared to analysts’ expectations of $93.07 million. During the same period last year, the firm earned $0.24 EPS. Cohu’s revenue for the quarter was up 17.4% compared to the same quarter last year.

A number of equities analysts recently commented on the company. BidaskClub raised Cohu from a “buy” rating to a “strong-buy” rating in a report on Saturday, May 12th. Dougherty & Co reaffirmed a “buy” rating on shares of Cohu in a report on Wednesday, February 21st. Stifel Nicolaus raised Cohu from a “hold” rating to a “buy” rating in a report on Tuesday, May 8th. Zacks Investment Research raised Cohu from a “sell” rating to a “buy” rating and set a $27.00 price target on the stock in a report on Wednesday, April 18th. Finally, ValuEngine raised Cohu from a “hold” rating to a “buy” rating in a report on Friday, February 2nd. One investment analyst has rated the stock with a hold rating, five have given a buy rating and one has issued a strong buy rating to the company’s stock. Cohu presently has a consensus rating of “Buy” and an average target price of $24.80.

In other Cohu news, Director William Bendush sold 3,000 shares of the firm’s stock in a transaction dated Thursday, May 17th. The stock was sold at an average price of $23.20, for a total transaction of $69,600.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. 3.88% of the stock is owned by company insiders.

A number of large investors have recently bought and sold shares of COHU. BlackRock Inc. increased its holdings in shares of Cohu by 7.9% in the first quarter. BlackRock Inc. now owns 3,993,647 shares of the semiconductor company’s stock worth $91,096,000 after purchasing an additional 293,537 shares during the last quarter. Cooke & Bieler LP increased its holdings in shares of Cohu by 11.4% in the first quarter. Cooke & Bieler LP now owns 1,077,278 shares of the semiconductor company’s stock worth $24,573,000 after purchasing an additional 110,498 shares during the last quarter. Royce & Associates LP increased its holdings in shares of Cohu by 2.4% in the fourth quarter. Royce & Associates LP now owns 1,067,533 shares of the semiconductor company’s stock worth $23,432,000 after purchasing an additional 25,019 shares during the last quarter. Systematic Financial Management LP increased its holdings in shares of Cohu by 9.8% in the first quarter. Systematic Financial Management LP now owns 858,128 shares of the semiconductor company’s stock worth $19,574,000 after purchasing an additional 76,478 shares during the last quarter. Finally, Northern Trust Corp increased its holdings in shares of Cohu by 10.9% in the first quarter. Northern Trust Corp now owns 444,241 shares of the semiconductor company’s stock worth $10,133,000 after purchasing an additional 43,602 shares during the last quarter. 87.24% of the stock is currently owned by institutional investors and hedge funds.

Cohu stock traded down $0.20 during trading on Friday, reaching $24.24. The company had a trading volume of 376,670 shares, compared to its average volume of 405,018. Cohu has a 52 week low of $15.55 and a 52 week high of $26.17. The stock has a market cap of $703.83 million, a P/E ratio of 18.09, a P/E/G ratio of 2.01 and a beta of 0.96. The company has a debt-to-equity ratio of 0.02, a quick ratio of 3.00 and a current ratio of 3.81.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 27th. Shareholders of record on Friday, June 15th will be issued a dividend of $0.06 per share. The ex-dividend date is Thursday, June 14th. This represents a $0.24 dividend on an annualized basis and a yield of 0.99%. Cohu’s dividend payout ratio is presently 17.91%.

About Cohu

Cohu, Inc, through its subsidiaries, engages in the development, manufacture, sale, and servicing of semiconductor test and inspection handlers, micro-electro mechanical system (MEMS) test modules, test contactors, and thermal sub-systems for semiconductor manufacturers and test subcontractors worldwide.

Get a free copy of the Zacks research report on Cohu (COHU)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Top 10 Value Stocks To Own For 2019

tags:VNDA,FCNCA,LEN,CATB,VBLT,LIVE,LPTH,JAZZ,PTR,PLG,

5 Ways an AXA U.S. Spinoff Could Affect You

Distributions Out of a Cash Value Life Insurance Policy

Brokers May Run 2018 HealthCare.gov Group Enrollment

(Bloomberg) — The man tasked with shepherding Aflac Inc.’s $110 billion portfolio is ready to make a wager on private equity to generate more income for the insurer.

The firm plans to bet on alternatives including private equity later this year, according to Chief Investment Officer Eric Kirsch. That follows a move last month to invest in real estate undergoing change such as renovations or upgrades, and aligns with Kirsch’s goal to have at least 2.5% of the insurer’s cash invested in growth assets, such as public equities, private equity and real estate.

Copyright 2017 Bloomberg. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

American Equity is cutting; Prudential wonders if it can; FBL wishes it could cut more.

Top 10 Value Stocks To Own For 2019: Vanda Pharmaceuticals Inc.(VNDA)

Advisors' Opinion:

• [By Stephan Byrd]

  Shares of Vanda Pharmaceuticals Inc. (NASDAQ:VNDA) have been assigned an average recommendation of “Buy” from the eight ratings firms that are covering the stock, Marketbeat reports. One research analyst has rated the stock with a hold recommendation and seven have issued a buy recommendation on the company. The average 1-year price target among brokerages that have covered the stock in the last year is $22.40.

Top 10 Value Stocks To Own For 2019: First Citizens BancShares, Inc.(FCNCA)

Advisors' Opinion:

• [By Max Byerly]

  American Century Companies Inc. reduced its holdings in First Citizens BancShares (NASDAQ:FCNCA) by 4.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 31,209 shares of the bank’s stock after selling 1,294 shares during the quarter. American Century Companies Inc. owned about 0.26% of First Citizens BancShares worth $12,897,000 at the end of the most recent quarter.

Top 10 Value Stocks To Own For 2019: Lennar Corp.(LEN)

Advisors' Opinion:

• [By ]

  In the Lightning Round, Cramer was bullish on T-Mobile US (TMUS) , Lennar (LEN) , Toll Brothers (TOL) , Tyson Foods (TSN) , JB Hunt Transport Services (JBHT) and International Paper (IP) .

• [By Chris Lange]

  The stock posting the largest daily percentage gain in the S&P 500 ahead of the close Wednesday was Lennar Corp. (NYSE: LEN) which rose over 10% to $63.10. The stock��s 52-week range is $48.52 to $72.17. Volume was 18.5 million compared to the daily average volume of nearly 5 million.

• [By Peter Graham]

  A long term performance chart shows KB Home along with large caps D.R. Horton, Inc (NYSE: DHI), Lennar Corporation (NYSE: LEN) and PulteGroup, Inc (NYSE: PHM) somewhat all taking off once Donald Trump was sworn in:�

• [By JJ Kinahan]

  Next week is big for housing numbers. March existing home sales figures are scheduled for  Monday and new home sales for March along with the February S&P Case-Shiller Home Price Index on Tuesday. As for homebuilders, Pulte Group, Inc. (NYSE: PHM) is scheduled to report  Q1 results Tuesday, and D.R. Horton Inc (NYSE: DHI) is scheduled to report fiscal Q2 numbers on Thursday. The industry already has seen strong Q1 results from Lennar Corporation (NYSE: LEN), and housing starts and building permits in March rose more than expected. These results, as well as those and the economic data from next week could provide clues for the industry going forward. After NVR, Inc. (NYSE: NVR) reports results this morning, Meritage Homes Corp. (NYSE: MTH) releases its Q1 results April 25. We’ll have to wait until next month for some of the other homebuilders, as well as from home improvement companies Home Depot, Inc. (NYSE: HD) and Lowe’s Companies Inc (NYSE: LOW), before we get a more complete snapshot of the housing market.

Top 10 Value Stocks To Own For 2019: Catabasis Pharmaceuticals, Inc.(CATB)

Advisors' Opinion:

• [By Max Byerly]

  These are some of the news articles that may have effected Accern’s analysis:

  Get Catabasis Pharmaceuticals alerts: Market Trends Toward New Normal in Church & Dwight Co., Rent-A-Center, Teradata, Catabasis Pharmaceuticals, Tronox, and Callaway Golf �� Emerging Consolidated Expectations, Analyst Ratings (finance.yahoo.com) Catabasis Pharmaceuticals Inc. – Receive News & Ratings Daily (thecasualsmart.com) Catabasis Pharmaceuticals (CATB) Upgraded by ValuEngine to Sell (americanbankingnews.com) Catabasis Pharmaceuticals to Report First Quarter 2018 Financial Results and Recent Corporate Developments on Thursday, May 10 (finance.yahoo.com) Catabasis Pharmaceuticals Inc (CATB) Given Consensus Rating of “Buy” by Brokerages (americanbankingnews.com)

  A number of analysts recently issued reports on CATB shares. Zacks Investment Research raised Catabasis Pharmaceuticals from a “hold” rating to a “buy” rating and set a $1.75 target price on the stock in a research report on Friday, January 26th. Wedbush reaffirmed an “outperform” rating and issued a $4.00 target price (down previously from $5.00) on shares of Catabasis Pharmaceuticals in a research report on Wednesday, February 14th. Finally, ValuEngine raised Catabasis Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research report on Wednesday, May 2nd. One analyst has rated the stock with a sell rating, one has given a hold rating and six have assigned a buy rating to the stock. Catabasis Pharmaceuticals presently has a consensus rating of “Buy” and a consensus target price of $5.18.

Top 10 Value Stocks To Own For 2019: Vascular Biogenics Ltd.(VBLT)

Advisors' Opinion:

• [By Lisa Levin]

  Check out these big penny stock gainers and losers

  Losers ReTo Eco-Solutions, Inc. (NASDAQ: RETO) fell 9.3 percent to $4.50 in pre-market trading. ProPhase Labs, Inc. (NASDAQ: PRPH) shares fell 8.5 percent to $4.50 in pre-market trading after dropping 3.53 percent on Thursday. Nordstrom, Inc. (NYSE: JWN) fell 7.5 percent to $47.10 in pre-market trading. Nordstrom reported upbeat results for its first quarter. Comparable-store sales rose 0.6 percent. Baidu, Inc. (NASDAQ: BIDU) shares fell 6 percent to $263.00 in pre-market trading. Baidu disclosed that its COO Qi Lu will step down in July 2018. Riot Blockchain, Inc. (NASDAQ: RIOT) shares fell 5.6 percent to $8.98 in pre-market trading after climbing 11.88 percent on Thursday. Applied Materials, Inc. (NASDAQ: AMAT) fell 5 percent to $51.30 in pre-market trading. Applied Materials reported stronger-than-expected results for its second quarter, but issued weak sales outlook for the third quarter. Blink Charging Co. (NASDAQ: BLNK) fell 5 percent to $7.61 in pre-market trading after rising 11.40 percent on Thursday. Illumina, Inc. (NASDAQ: ILMN) shares fell 4.7 percent to $255.77 in pre-market trading. Vascular Biogenics Ltd (NASDAQ: VBLT) fell 4.6 percent to $2.10 in pre-market trading after reporting a first-quarter earnings miss. Campbell Soup Company (NYSE: CPB) fell 3.3 percent to $37.60 in pre-market trading. Campbell Soup reported upbeat Q3 earnings, but sales missed estimates. The company also lowered its FY18 outlook. ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares fell 2.7 percent to $17.65 in pre-market trading after reporting a 7.2 million common stock offering
• [By Lisa Levin] Companies Reporting Before The Bell Walmart Inc. (NYSE: WMT) is estimated to report quarterly earnings at $1.13 per share on revenue of $120.51 billion. J. C. Penney Company, Inc. (NYSE: JCP) is expected to report quarterly loss at $0.2 per share on revenue of $2.63 billion. Dillard's, Inc. (NYSE: DDS) is projected to report quarterly earnings at $2.77 per share on revenue of $1.46 billion. The Children's Place, Inc. (NASDAQ: PLCE) is estimated to report quarterly earnings at $2.21 per share on revenue of $444.14 million. Manchester United plc (NYSE: MANU) is expected to report quarterly loss at $1.35 per share on revenue of $193.67 million. Teekay Corporation (NYSE: TK) is estimated to report quarterly loss at $0.08 per share on revenue of $296.76 million. KEMET Corporation (NYSE: KEM) is projected to report quarterly earnings at $0.41 per share on revenue of $306.72 million. Vascular Biogenics Ltd. (NASDAQ: VBLT) is estimated to report a quarterly loss at $0.21 per share. Teekay Offshore Partners L.P. (NYSE: TOO) is expected to report quarterly earnings at $0.04 per share on revenue of $272.04 million. Albireo Pharma, Inc. (NASDAQ: ALBO) is expected to report quarterly earnings at $1.77 per share on revenue of $31.32 million.

   

Top 10 Value Stocks To Own For 2019: Live Ventures Incorporated(LIVE)

Advisors' Opinion:

• [By Ethan Ryder]

  Live Ventures (NASDAQ: LIVE) and PennantPark Investment (NASDAQ:PNNT) are both small-cap computer and technology companies, but which is the better business? We will compare the two companies based on the strength of their valuation, dividends, analyst recommendations, risk, earnings, profitability and institutional ownership.

Top 10 Value Stocks To Own For 2019: LightPath Technologies, Inc.(LPTH)

Advisors' Opinion:

• [By Lisa Levin] Gainers Euro Tech Holdings Company Limited (NASDAQ: CLWT) shares rose 14.1 percent to $3.65 in the pre-market trading session after reporting 2017 year-end results. LightPath Technologies, Inc. (NASDAQ: LPTH) rose 13.3 percent to $2.43 in pre-market trading after reporting a third-quarter earnings beat. MYnd Analytics, Inc. (NASDAQ: MYND) rose 10.5 percent to $3.49 in pre-market trading. MYnd Analytics reported a Q2 net loss of $2.7 million on revenue of $459,900. SORL Auto Parts, Inc. (NASDAQ: SORL) shares rose 8.4 percent to $5.68 in pre-market trading after reporting upbeat Q1 results. Famous Dave's of America, Inc. (NASDAQ: DAVE) shares rose 7.7 percent to $8.40 in pre-market trading after the company reported upbeat earnings for its first quarter on Monday. Xenon Pharmaceuticals Inc. (NASDAQ: XENE) rose 7.5 percent to $6.45 in pre-market trading after the company presented XEN901 Phase 1 clinical update and XEN1101 TMS pharmacodynamic Phase 1 data. Mimecast Ltd (NASDAQ: MIME) rose 6.5 percent to $43.50 in pre-market trading following a first-quarter sales beat. Boxlight Corporation (NASDAQ: BOXL) rose 6 percent to $12.50 in pre-market trading after surging 77.44 percent on Monday. Intellia Therapeutics, Inc. (NASDAQ: NTLA) shares rose 6 percent to $26.05 in pre-market trading after climbing 3.58 percent on Monday. PPDAI Group Inc. (NASDAQ: PPDF) rose 4.7 percent to $7.20 in pre-market trading following Q1 results. Xunlei Limited (NASDAQ: XNET) rose 4.1 percent to $13.88 in pre-market trading after gaining 2.54 percent on Monday. Valeant Pharmaceuticals International, Inc. (NYSE: VRX) shares rose 4.5 percent to $21.73 in pre-market trading. Mizuho upgraded Valeant from Neutral to Buy. Bovie Medical Corporation (NYSE: BVX) rose 4.1 percent to $3.80 in pre-market trading after reporting a first-quarter sales beat. Myomo, Inc. (NYSE: MYO) rose 3.4 percent to $4.00 in pre-market trading after jumping 23.25 percent o

Top 10 Value Stocks To Own For 2019: Jazz Pharmaceuticals Inc.(JAZZ)

Advisors' Opinion:

• [By Brian Feroldi, Keith Speights, and Sean Williams]

  So which biotechnology stocks do we think are smart buys right now? We asked these three Motley Fool investors -- all healthcare experts -- to weigh in, and they picked�Vertex Pharmaceuticals (NASDAQ:VRTX), Jazz Pharmaceuticals (NASDAQ:JAZZ), and�Neurocrine Biosciences (NASDAQ:NBIX).

• [By Keith Speights]

  But at least three of the biotechs singled out by the FDA deserve to be on another list -- investors' buy lists. Here's why Celgene (NASDAQ:CELG), Gilead Sciences (NASDAQ:GILD), and Jazz Pharmaceuticals (NASDAQ:JAZZ) look like great stock picks right now.

• [By Lisa Levin]

   

  Companies Reporting After The Bell Marriott International, Inc. (NASDAQ: MAR) is projected to post quarterly earnings at $1.22 per share on revenue of $5.72 billion. Electronic Arts Inc. (NASDAQ: EA) is estimated to post quarterly earnings at $1.04 per share on revenue of $5.68 billion. The Walt Disney Company (NYSE: DIS) is projected to post quarterly earnings at $1.68 per share on revenue of $14.05 billion. Papa John's International, Inc. (NASDAQ: PZZA) is expected to post quarterly earnings at $0.62 per share on revenue of $441.73 million. Jazz Pharmaceuticals plc (NASDAQ: JAZZ) is projected to post quarterly earnings at $2.77 per share on revenue of $434.87 million. Sun Life Financial Inc. (NYSE: SLF) is estimated to post quarterly earnings at $0.89 per share on revenue of $6.38 billion. LATAM Airlines Group S.A. (NYSE: LTM) is expected to post quarterly earnings at $0.16 per share on revenue of $2.70 billion. Liberty Global plc (NASDAQ: LBTYA) is projected to post quarterly earnings at $0.02 per share on revenue of $4.05 billion. TripAdvisor, Inc. (NASDAQ: TRIP) is expected to post quarterly earnings at $0.16 per share on revenue of $362.11 million. The Wendy's Company (NASDAQ: WEN) is projected to post quarterly earnings at $0.1 per share on revenue of $379.98 million. A-Mark Precious Metals, Inc. (NASDAQ: AMRK) is expected to post quarterly earnings at $0.06 per share on revenue of $1.69 billion. Monster Beverage Corporation (NASDAQ: MNST) is estimated to post quarterly earnings at $0.4 per share on revenue of $849.38 million. Convergys Corporation (NYSE: CVG) is expected to post quarterly earnings at $0.4 per share on revenue of $670.10 million. ScanSource, Inc. (NASDAQ: SCSC) is projected to post quarterly earnings at $0.7 per share on revenue of $875.91 million. KAR Auction Services, Inc. (NYSE: KAR) is expected to post quarterly earnings at $0.76 per share on revenue of $923.13
• [By Max Byerly]

  Jazz Pharmaceuticals (NASDAQ:JAZZ) was downgraded by equities research analysts at BidaskClub from a “hold” rating to a “sell” rating in a research report issued on Friday.

• [By Lee Jackson]

  This top company is a favorite across Wall Street.�Jazz Pharmaceuticals PLC (NASDAQ: JAZZ) is a biopharmaceutical company that identifies, develops and commercializes pharmaceutical products for various medical needs in the United States, Europe and elsewhere. The company has a portfolio of products and product candidates with a focus in the areas of sleep and hematology/oncology.

Top 10 Value Stocks To Own For 2019: PetroChina Company Limited(PTR)

Advisors' Opinion:

• [By Max Byerly]

  ILLEGAL ACTIVITY NOTICE: “Somewhat Favorable News Coverage Somewhat Unlikely to Affect PetroChina (PTR) Stock Price” was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this piece on another domain, it was illegally copied and reposted in violation of United States and international copyright law. The original version of this piece can be viewed at https://www.tickerreport.com/banking-finance/3368551/somewhat-favorable-news-coverage-somewhat-unlikely-to-affect-petrochina-ptr-stock-price.html.

• [By Lisa Levin] Gainers Shineco, Inc. (NASDAQ: TYHT) rose 34.7 percent to $2.29 in pre-market trading following Q3 results. Shineco posted Q3 earnings of $0.21 per share on sales of $13.3 million. Carver Bancorp, Inc. (NASDAQ: CARV) rose 15.8 percent to $12.74 in pre-market trading after surging 201.37 percent on Thursday. LiveXLive Media, Inc. (NASDAQ: LIVX) shares rose 11.5 percent to $7.75 in pre-market trading after climbing 64.50 percent on Thursday. Eiger BioPharmaceuticals, Inc. (NASDAQ: EIGR) rose 9 percent to $18.30 in pre-market trading after climbing 41.77 percent on Thursday. AmTrust Financial Services Inc (NASDAQ: AFSI) rose 6.2 percent to $14.25 in pre-market trading after a 13D filing from Carl Icahn shows a new 9.38 percent stake in the company. The filing also shows language from Icahn that strongly opposes a go-private transaction. Cerner Corporation (NASDAQ: CERN) rose 5.6 percent to $64.02 in pre-market trading after the Department of Veterans Affairs reported an agreement with Cerner Government Services, Inc. to provide seamless care for veterans. PetroChina Company Limited (NYSE: PTR) shares rose 5.3 percent to $82.05 in pre-market trading. TC PipeLines, LP (NYSE: TCP) shares rose 5.2 percent to $26.59 in the pre-market trading session. IQVIA Holdings Inc. (NYSE: IQV) shares rose 4.8 percent to $102.50 in pre-market trading as the company pulled secondary offering 'in light of recent market conditions'. Axon Enterprise, Inc. (NASDAQ: AAXN) rose 4.5 percent to $59.70 in pre-market trading. On Thursday, Axon priced its 4.3 million share offering of common stock at $53 per share. The Trade Desk, Inc. (NASDAQ: TTD) rose 4.5 percent to $84 in pre-market trading. PetIQ Inc (NASDAQ: PETQ) rose 3.9 percent to $18.96 in pre-market trading after a 13G filing shows a new 5.05 percent stake by the State of New Jersey's Division of Investment. Mattel, Inc. (NASDAQ: MAT) shares rose 3.7 percent to $15.85 in pre-market

Top 10 Value Stocks To Own For 2019: Platinum Group Metals Ltd.(PLG)

Advisors' Opinion:

• [By Ethan Ryder]

  Shares of Platinum Group Metals (TSE:PTM) (NYSE:PLG) traded down 18.2% during mid-day trading on Friday . The stock traded as low as C$0.18 and last traded at C$0.18. 643,238 shares traded hands during mid-day trading, an increase of 400% from the average session volume of 128,626 shares. The stock had previously closed at C$0.22.

Norsk Hydro (NHYDY) Given Average Recommendation of “Hold” by Brokerages

Norsk Hydro (OTCMKTS:NHYDY) has earned a consensus recommendation of “Hold” from the eight brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and three have assigned a buy rating to the company.

A number of research analysts have recently commented on NHYDY shares. Zacks Investment Research upgraded Norsk Hydro from a “hold” rating to a “buy” rating and set a $7.75 price target for the company in a research note on Thursday, March 8th. ValuEngine lowered Norsk Hydro from a “buy” rating to a “hold” rating in a research report on Wednesday, May 2nd. Deutsche Bank raised Norsk Hydro from a “hold” rating to a “buy” rating in a research report on Wednesday, April 18th. Finally, Goldman Sachs Group lowered Norsk Hydro from a “neutral” rating to a “sell” rating in a research report on Monday, May 7th.

Get Norsk Hydro alerts:

Norsk Hydro traded down $0.05, hitting $6.18, on Monday, according to MarketBeat Ratings. 9,150 shares of the company’s stock were exchanged, compared to its average volume of 43,434. The company has a debt-to-equity ratio of 0.10, a current ratio of 1.64 and a quick ratio of 1.01. Norsk Hydro has a 52 week low of $5.11 and a 52 week high of $7.93. The stock has a market capitalization of $13.07 billion, a PE ratio of 12.88, a PEG ratio of 0.45 and a beta of 0.95.

Norsk Hydro (OTCMKTS:NHYDY) last released its earnings results on Wednesday, April 25th. The industrial products company reported $0.13 earnings per share for the quarter, hitting the consensus estimate of $0.13. Norsk Hydro had a return on equity of 10.19% and a net margin of 7.10%. The firm had revenue of $5.15 billion during the quarter. sell-side analysts expect that Norsk Hydro will post 0.76 earnings per share for the current year.

Norsk Hydro Company Profile

Norsk Hydro ASA operates as an integrated aluminum company worldwide. It operates in six segments: Bauxite & Alumina, Primary Metal, Metal Markets, Rolled Products, Extruded Solutions, and Energy. The Bauxite & Alumina segment engages in bauxite mining activities, production of alumina, and related commercial activities, as well as the sale of alumina.

525,689 Shares in EOG Resources Inc (EOG) Acquired by Rockefeller Capital Management L.P.

Rockefeller Capital Management L.P. bought a new stake in EOG Resources Inc (NYSE:EOG) in the 1st quarter, HoldingsChannel.com reports. The firm bought 525,689 shares of the energy exploration company’s stock, valued at approximately $55,338,000.

A number of other large investors have also recently modified their holdings of the stock. Silvant Capital Management LLC acquired a new stake in EOG Resources during the first quarter worth approximately $8,719,000. Swedbank acquired a new stake in EOG Resources during the first quarter worth approximately $127,489,000. Usca Ria LLC lifted its position in EOG Resources by 222.0% during the first quarter. Usca Ria LLC now owns 35,775 shares of the energy exploration company’s stock worth $3,766,000 after acquiring an additional 24,666 shares during the last quarter. Exencial Wealth Advisors LLC lifted its position in EOG Resources by 2.4% during the first quarter. Exencial Wealth Advisors LLC now owns 46,671 shares of the energy exploration company’s stock worth $4,913,000 after acquiring an additional 1,093 shares during the last quarter. Finally, King Luther Capital Management Corp lifted its position in EOG Resources by 1.8% during the first quarter. King Luther Capital Management Corp now owns 1,734,229 shares of the energy exploration company’s stock worth $182,562,000 after acquiring an additional 30,162 shares during the last quarter. Institutional investors and hedge funds own 85.43% of the company’s stock.

Get EOG Resources alerts:

EOG has been the subject of several research reports. Stifel Nicolaus set a $146.00 price objective on shares of EOG Resources and gave the stock a “buy” rating in a research report on Monday, April 23rd. UBS initiated coverage on shares of EOG Resources in a research report on Wednesday, March 7th. They set a “buy” rating and a $125.00 price objective for the company. Piper Jaffray set a $122.00 price objective on shares of EOG Resources and gave the stock a “buy” rating in a research report on Wednesday, March 14th. Jefferies Group set a $111.00 price objective on shares of EOG Resources and gave the stock a “hold” rating in a research report on Thursday, March 8th. Finally, Tudor Pickering downgraded shares of EOG Resources from a “buy” rating to a “hold” rating in a research report on Thursday, May 10th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and fifteen have issued a buy rating to the company. The stock has a consensus rating of “Buy” and an average price target of $122.57.

Shares of EOG Resources opened at $125.79 on Friday, according to Marketbeat. EOG Resources Inc has a 12 month low of $81.99 and a 12 month high of $126.48. The company has a market cap of $72.81 billion, a PE ratio of 112.31, a price-to-earnings-growth ratio of 3.43 and a beta of 1.05. The company has a current ratio of 1.26, a quick ratio of 1.06 and a debt-to-equity ratio of 0.36.

EOG Resources (NYSE:EOG) last announced its earnings results on Thursday, May 3rd. The energy exploration company reported $1.19 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.80 by $0.39. The company had revenue of $3.68 billion for the quarter, compared to analysts’ expectations of $3.51 billion. EOG Resources had a net margin of 26.00% and a return on equity of 8.19%. The business’s revenue for the quarter was up 41.0% on a year-over-year basis. During the same period last year, the firm earned $0.15 earnings per share. equities analysts predict that EOG Resources Inc will post 4.8 EPS for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 31st. Investors of record on Saturday, July 7th will be paid a $0.185 dividend. The ex-dividend date of this dividend is Monday, July 16th. This represents a $0.74 dividend on an annualized basis and a yield of 0.59%. EOG Resources’s dividend payout ratio (DPR) is 66.07%.

In related news, President Gary L. Thomas sold 50,000 shares of EOG Resources stock in a transaction that occurred on Thursday, May 17th. The shares were sold at an average price of $125.36, for a total value of $6,268,000.00. Following the transaction, the president now directly owns 988,947 shares of the company’s stock, valued at $123,974,395.92. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO Ann D. Janssen sold 1,258 shares of EOG Resources stock in a transaction that occurred on Thursday, May 17th. The shares were sold at an average price of $126.35, for a total transaction of $158,948.30. Following the completion of the transaction, the chief accounting officer now directly owns 53,828 shares in the company, valued at $6,801,167.80. The disclosure for this sale can be found here. Insiders sold 67,453 shares of company stock worth $8,423,028 over the last three months. 0.51% of the stock is currently owned by insiders.

About EOG Resources

EOG Resources, Inc, together with its subsidiaries, explores for, develops, produces, and markets crude oil and natural gas. The company's principal producing areas are located in New Mexico, North Dakota, Texas, Utah, and Wyoming in the United States; and the Republic of Trinidad and Tobago, the United Kingdom, the People's Republic of China, and Canada.

Want to see what other hedge funds are holding EOG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for EOG Resources Inc (NYSE:EOG).

Why Is the Market Rewarding Harley-Davidson and Punishing Polaris?

One of the best reasons that investing experts give to explain why you shouldn't short stocks is that the market can remain irrational longer than you can remain solvent. For proof of that irrationality, you need look no further than Harley-Davidson (NYSE:HOG) and Polaris Industries (NYSE:PII).

In the weeks since both companies reported first-quarter earnings near the end of April, Harley-Davidson's stock price has gained almost 4%, while Polaris shares tumbled as much as 13%. But it was Polaris that reported solid numbers, while Harley's report was yet another disaster.

HOG data by YCharts

Happy days are here again

Beyond management's happy talk, it's hard to make out a reason why investors aren't punishing Harley Davidson stock. Despite U.S. sales continuing their sickening slide -- down 12% year over year -- CEO Matt Levatich says his team is cobbling together a strategy that'll turn things around. What that strategy will be, we don't know, but, boy, it's going to be awesome!

It'll have to be for Harley to hit its goal of bringing in 2 million new U.S. riders over the next 10 years, delivering 100 new bike models in that time frame, and increasing its international volumes so that foreign markets account for half of all�Harley Davidson bikes sold.

Polaris, on the other hand, reported continued strong demand for its Indian Motorcycle brand with wholegood sales rising by double-digit percentages, and retail demand climbing by low single-digit percentages. Moreover, sales of off-road vehicles (ORVs) were exceptionally strong, with shipments for its Ranger, RZR, and ATVs driving wholegoods sales 17% higher.

Image source: Polaris Industries.

Because Polaris has had to issue a seemingly endless string of recalls of its ORVs due to fire hazards, the fact that its lineup is still holding its own and leading the industry in sales is remarkable.

And where Harley has essentially told investors, "trust us, we'll turn things around," Polaris gave specifics, raised the low end of its full-year guidance, and said it expects sales to grow 4% to 6% over 2017.

Hitting the brakes

While Polaris provided some solid numbers for investors to sink their teeth into compared to the feel-good sentiments of its rival, bearish investors may have been reacting to the implication that its sales will slow for the rest of the year.

Because overall Q1 sales came in 12% higher than a year ago, guidance pointing to full-year growth of just half of that -- or worse -- suggests Polaris expects to run into some headwinds. Also, the midpoint of the earnings-per-share guidance range come in at $6.12, -- $0.05 per share below the Wall Street consensus.

Even so, that's still better than Harley's guidance. While the big bike maker doesn't issue sales or earnings guidance, it did say it expects shipments of motorcycles to be down 2% to 4% from last year. It bases that on the steep 15% drop in Q1 and an expected 11% to 14% decline in Q2 -- after which it asserts sales will boomerang, and shoot 12% higher in the second half.

Shipments aren't sales, and fluctuations in that statistic can have more to do with maintaining dealer inventory -- but if its bikes aren't moving off the showroom floors, it's going to have a hard time adding even more.

Image source: Harley-Davidson.

Good for the goose, not the gander

The market seems to be making a judgment based on the hard numbers Polaris Industries has posted compared to the vague but optimistic talk from Harley-Davidson. Also worth considering: Shares of Polaris trade at 30 times trailing earnings, while Harley's P/E is half of that-- but an argument can be made that Polaris' better business prospects justify the premium it is being accorded.

On one metric, though, Harley-Davidson looks exceptionally cheap: It trades at less than 10 times its free cash flow -- a bargain valuation or a sign that things could still get worse.

By contrast, considering Polaris Industries' diversified revenue streams and the outlook for growth in its various segments, there's no reason its stock should have received the drubbing it has while Harley-Davidson's shares emerged from the past few weeks unscathed. It does suggest the market remains as illogical as ever.